Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Tim Lugo is an analyst at William Blair. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/31/2024
Buy Now | Get Alert | ||||||||
---|---|---|---|---|---|---|---|---|---|
07/31/2024 | APLT | Buy Now | Applied Therapeutics | $5.80 | — | — | Initiates | → Outperform | Get Alert |
04/15/2024 | LENZ | Buy Now | LENZ Therapeutics | $24.95 | — | — | Initiates | → Outperform | Get Alert |
03/28/2024 | SLDB | Buy Now | Solid Biosciences | $9.17 | 336.21% | → $40 | Initiates | → Outperform | Get Alert |
03/12/2024 | ZVRA | Buy Now | Zevra Therapeutics | $5.95 | — | — | Initiates | → Outperform | Get Alert |
01/29/2024 | ABBV | Buy Now | AbbVie | $186.90 | — | — | Upgrade | Market Perform → Outperform | Get Alert |
12/18/2023 | ALLK | Buy Now | Allakos | $0.94 | — | — | Upgrade | Market Perform → Outperform | Get Alert |
11/13/2023 | ACRS | Buy Now | Aclaris Therapeutics | $1.34 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
11/01/2023 | EYEN | Buy Now | Eyenovia | $1.40 | — | — | Initiates | → Outperform | Get Alert |
09/21/2023 | TVTX | Buy Now | Travere Therapeutics | $9.50 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
09/20/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $10.97 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
07/25/2023 | ABBV | Buy Now | AbbVie | $186.90 | — | — | Initiates | → Market Perform | Get Alert |
01/04/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $10.97 | — | — | Initiates | → Outperform | Get Alert |
07/22/2022 | VTGN | Buy Now | VistaGen Therapeutics | $3.46 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
03/08/2022 | BBI | Buy Now | Brickell Biotech | — | — | — | Initiates | → Outperform | Get Alert |
12/22/2021 | ALLK | Buy Now | Allakos | $0.94 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
11/22/2021 | BMRN | Buy Now | Biomarin Pharmaceutical | $85.23 | — | — | Upgrade | Market Perform → Outperform | Get Alert |